Scientists believe that air pollution could be a major cause behind the rise in global lung cancer cases in people that have ...

Heather Wakelee, MD, Stanford University, discusses the pros and cons of different durations of immunotherapy in non-small cell lung cancer (NSCLC) and the future outlook for patient-specific care.

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

THE proportion of people diagnosed with lung cancer who’ve never smoked is increasing, the World Health Organization (WHO) ...

This guide will help you understand how NSCLC is treated, potential side effects, and how to navigate life beyond cancer.

This study suggests that immunotherapy may not be the optimal ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 — A team of doctors and researchers have identified a new ...

The study also found that the sub-type of lung cancer was also found to account for 53-70 per cent of lung cancer cases in ...

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies.

The report discusses key statistics, including current and projected market sizes, while also delving into C-MET Metastatic Non-small Cell Lung Cancer symptoms and their impact on patients ...